DRKS00024808已完成不适用
Collection of blood samples for analytical performance evaluation under the IVDR of in vitro test systems in the area of Allergy and Nutrition Care - IVDR-All/NC-01
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 26
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •1. ability to understand and willingness to sign a written consent form.
- •2. females and males 18 years of age or older.
- •3. Presence of allergy(s) and/or food intolerance(s) (self-reported).
- •4. collection of the required volume of whole blood and capillary blood possible.
- •5. min. 50 kg body weight (in case of allergy).
排除标准
- •6. pregnant and lactating women
- •8. increased bleeding tendency, or known blood clotting disorder
- •9. intake of immunosuppressants
- •10. intake of Omalizumab
- •11. an event due to which, in the opinion of the principal investigator, the subject is not suitable for participation in the study.
研究者
相似试验
招募中
不适用
Collection of blood samples for the evaluation of the analytical performance of two new in vitro test systems for tuberculosis diagnosticsA15-A19TuberculosisDRKS00027129R-Biopharm AG636
招募中
不适用
Collection of blood samples for research and development of an IP-10 TB-CLIA-AssayA15-A19TuberculosisDRKS00030861R-Biopharm AG200
进行中（未招募）
Unknown
Blood collection for the development of a point-of-care troponin platformDiagnosis of myocardial infarctionCirculatory SystemISRCTN13589405Psyros Diagnostics120
招募中
不适用
Study of blood and sputum samples of healthy humans and patients for cancer research.CTRI/2023/01/048765Oxford Cancer Analytics
已完成
不适用
Trial for collection of blood samples from healed Covid-19 patients - research and development of in-vitro diagnosticsSARS-CoV-2 infectionCovid-19U07.1COVID-19, virus identifiedDRKS00022406R-Biopharm AG50